Campbell Soup Company
NASDAQ:CPBPackaged Foods
-$0.08 today
- Market cap
- $7.27B
- Beta
- 0.01
- P/E (TTM)
- 10.3
- EPS (TTM)
- $2.04
- Dividend yield
- 7.42%
Volume 7.75M
Average 8.60M
CPB Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Campbell Soup CompanyNASDAQ: CPB
Research & Development · Q4 FY2026 · quarter ended Aug 2026
Research & development growth accelerates
Q4 FY2026 research & development of $28M rose 7.7% year over year, ahead of the -1.0% change in trailing-twelve-month research & development. Sequentially, it rose 12.0% from the prior quarter. Over 3 fiscal years it compounded at +2.5% a year.
Context
- Research & development amounted to 1.0% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +7.7% holds above the trailing-twelve-month pace of -1.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 99M USD
- Year-over-year change
- -1.0%
- 4-year CAGR
- +3.3%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-08-02 | 99M | -1.0% |
| FY2025 | 2025-08-03 | 100M | -2.0% |
| FY2024 | 2024-07-31 | 102M | +10.9% |
| FY2023 | 2023-07-31 | 92M | +5.7% |
| FY2022 | 2022-07-31 | 87M | — |
Research & Development vs competitors
How CPB compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -1.0% is the highest of 2, against a peer median of -100.0%.
- Research & development amounts to 1.0% of revenue for CPB, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $99M USD | -1.0% | +2.5% | 1.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Aug 2026 | $0 USD | — | — | 0.0% | |
| LTM Jul 2026 | $0 USD | — | — | 0.0% | |
| LTM Jul 2026 | $0 USD | — | — | 0.0% | |
| LTM Aug 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | +19.1% | 0.0% | |
| LTM Mar 2026 | €0 EUR | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Apr 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CPB) | — | -100.0% | +19.1% | 0.0% | |
Competitors are the stored peer set for CPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jul 2022 | FY2023 Jul 2023 | FY2024 Jul 2024 | FY2025 Aug 2025 | FY2026 Aug 2026 |
|---|---|---|---|---|---|
| Revenue | 8.56B | 9.36B | 9.64B | 10.25B | 9.74B |
| Cost of Revenue | 5.94B | 6.44B | 6.67B | 7.13B | 7B |
| Gross Profit | 2.63B | 2.92B | 2.97B | 3.12B | 2.74B |
| Gross Margin | 30.7% | 31.2% | 30.8% | 30.4% | 28.1% |
| Research & Development | 87M | 92M | 102M | 100M | 99M |
| Selling, General & Admin | 1.35B | 1.47B | 1.57B | 1.6B | 1.55B |
| Operating Expenses | 1.48B | 1.61B | 1.75B | 1.77B | 1.89B |
| Depreciation & Amortization | 337M | 387M | 411M | 434M | 413M |
| EBITDA | 1.5B | 1.7B | 1.42B | 1.58B | 1.27B |
| EBITDA Margin | 17.5% | 18.2% | 14.7% | 15.4% | 13.0% |
| Operating Income | 1.15B | 1.31B | 1.23B | 1.35B | 852M |
| Operating Margin | 13.4% | 14.0% | 12.7% | 13.2% | 8.7% |
| Interest Income | 1M | 4M | 6M | 17M | 0 |
| Interest Expense | 189M | 188M | 249M | 345M | 323M |
| Other Income / Expenses | (173M) | (184M) | (469M) | (557M) | (323M) |
| Income Before Tax | 975M | 1.13B | 757M | 796M | 529M |
| Pre-Tax Margin | 11.4% | 12.1% | 7.9% | 7.8% | 5.4% |
| Income Tax Expense | 218M | 270M | 190M | 194M | 124M |
| Net Income | 757M | 858M | 567M | 602M | 403M |
| Net Margin | 8.8% | 9.2% | 5.9% | 5.9% | 4.1% |
| EPS (Basic) | 2.51 | 2.87 | 1.90 | 2.02 | 1.34 |
| EPS (Diluted) | 2.51 | 2.85 | 1.89 | 2.01 | 1.31 |
| Weighted Avg Shares | 301M | 299M | 300M | 298M | 298M |
| Weighted Avg Shares (Diluted) | 302M | 301M | 300M | 300M | 300M |
Campbell Soup Company
NASDAQ:CPB
Intrinsic Alpha fair value
Locked
Current Price
$24.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.